Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Carl A. Patow is active.

Publication


Featured researches published by Carl A. Patow.


Laryngoscope | 1992

Granular cell tumors of the trachea

Deborah Mitchell Burton; Dennis K. Heffner; Carl A. Patow

In contrast to the relative frequency of granular cell tumors (GCT) in the larynx and bronchi, the occurrence of these tumors in the trachea is rare. A 50‐year review of the English‐language literature disclosed only 24 described cases of tracheal GCT. This report reviews the clinicopathologic data from those 24 cases, along with the data from 2 cases obtained via a personal communication and the data from 4 previously unpublished cases obtained from a 30‐year review of the Armed Forces Institute of Pathology archives. Tracheal resection was the predominant mode of therapy and often was performed as a salvage procedure for failed endoscopic excisions. Recommendations for a more uniform approach to surgical management are provided.


American Journal of Otolaryngology | 1984

Analysis of human nasal mucous glycoproteins

Carl A. Patow; James H. Shelhamer; Zvi Marom; Carolea Logun; Michael Kaliner

Human nasal turbinates were cultured in the presence of 3H-glucosamine, which is incorporated into nasal mucous glycoproteins. Nasal mucous glycoprotein was then characterized biochemically, and the effects of various neurohormones and immunologic stimulation on mucous glycoprotein release were analyzed. Fractionation of nasal mucous glycoprotein by gel filtration chromatography revealed a molecular size range of 2 to 200 X 10(5) (as judged by protein markers) but displayed a single, acidic charge, as reflected both in a narrow elution pattern from DEAE-cellulose and a sharp isoelectric focusing point of 2.6. Highly enriched nasal mucous glycoprotein preparations consisted of 80 per cent carbohydrate and 20 per cent protein (by weight) and included enzymatically cleavable carbohydrate side chains with molecular weights of 1,600 to 1,800. Thus, nasal mucous glycoproteins are a family of molecules that express uniform acidic charge characteristics and a wide range of molecular sizes. Cholinergic stimulation of atropine-inhibitable muscarinic receptors increased nasal mucous glycoprotein release in a dose-related manner, as did alpha-adrenergic stimulation. However, beta-adrenergic stimulation did not affect mucous glycoprotein release. Immunologic stimulation of nasal mast cells by either reversed anaphylaxis or antigen challenge after passive sensitization caused both histamine release and increased mucous glycoprotein release. Thus, nasal turbinates provide an accessible source of tissue for the analysis of nasal mucus secretion and mast cell degranulation and may provide a model for the study of pharmacologic approaches to the universally experienced discomfort of rhinorrhea.


Otolaryngology-Head and Neck Surgery | 1984

Kaposi's Sarcoma of the Head and Neck in the Acquired Immune Deficiency Syndrome

Carl A. Patow; Ronald G. Steis; Dan L. Longo; Cheryl M. Reichert; Peggy A. Findlay; Dorothy A. Potter; Henry Masur; H. Clifford Lane; Anthony S. Fauci; Abe M. Macher

Since 1981 a new syndrome of acquired immune deficiency (AIDS) has been recognized. Male homosexuals, male and female intravenous drug abusers, and recipients of blood products (i.e., hemophiliacs) appear to be the populations at risk. The syndrome has been manifested by community-acquired opportunistic infections and/or Kaposis sarcoma (KS). Otolaryngologic manifestations of AIDS are not infrequent. Thirteen AIDS patients at the National Institutes of Health with KS of the head and neck region are presented. All 13 patients were homosexual or bisexual males. Nine initially presented with KS, five with KS of the head or neck. As a group the patients demonstrated lesions involving the oropharyngeal, tracheobronchial, and gastrointestinal regions. Their clinical course and complications are presented in detail. The mortality rate in this subgroup of AIDS patients is extraordinarily high (62%), with an average longevity of 11 months following initial diagnosis.


Otolaryngology-Head and Neck Surgery | 1982

Cervical Heterotopic Salivary Gland Neoplasms: A Diagnostic Dilemma

Zajtchuk Jt; Carl A. Patow; Hyams Vj

Salivary gland neoplasms found within cervical lymph nodes and occurring as neck masses probably represent primary tumors of heterotopic salivary gland tissue. Five new cases of cervical heterotopic salivary gland neoplasms having appropriate clinical follow-up are added to the literature from ten case reports reviewed at the Armed Forces Institute of Pathology from 1956 to 1980. The rarity of these tumors precludes a definitive statement regarding the treatment of this primary tumor of the neck. The most appropriate follow-up may be long-term serial clinical evaluations of the head and neck after excision of the neck mass.


Otolaryngology-Head and Neck Surgery | 1994

Tympanic membrane perforation in survivors of a SCUD missile explosion

Carl A. Patow; Jeffrey W. Bartels; Kenneth T. Dodd

On February 25, 1990, an Iraqi SCUD missile exploded inside a building housing United States military personnel in Dhahran, Kingdom of Saudi Arabia. One hundred seventy-two individuals who were near the impact site at the time of the blast were interviewed and examined to determine blast injury to the ear. Tympanic membrane (TM) perforation was used as the clinical marker for aural blast injury. Thirty-four personnel had unilateral TM perforation and 28 had bilateral TM perforation. Eighty-six sustained sufficient injury to be hospitalized. Fifty-nine of hospitalized personnel (70%) had TM perforation. Of a total of 90 TM perforations, 39% were estimated to be 25% or less of the tympanic membrane surrface area, 36% were 26% to 50%, 16% were 51% to 75%, and 10% were greater than 75%. Morphology of the perforations and estimated proximity to the blast were documented. Personnel distant from the blast, in open doorways or wearing headphones, had relative protection from TM perforation. Historic nuclear blast data were used to estimate the SCUD blast waveform based on measurements of the SCUD impact crater. A mathematical model based on the estimated waveform was validated against the actual field data by comparing the proximity and incidence of TM perforations in the SCUD missile explosion.


Otolaryngology-Head and Neck Surgery | 1984

Pharyngeal Obstruction by Kaposi's Sarcoma in a Homosexual Male with Acquired Immune Deficiency Syndrome

Robert A. Dobie; Carl A. Patow; Thomas W. Stark; Peggy A. Findlay; Ronald G. Steis; Dan L. Longo; Henry Masur; Abe M. Macher

A homosexual man with AIDS developed multifocal KS with involvement of the palate, larynx, trachea, and esophagus. Symptoms included dysphagia and gagging with resultant inanition. Short-course local radiation therapy effectively resolved the mucosal KS lesions in the treated areas. Other otolaryngologic manifestations included herpes stomatitis and oral candidiasis.


Otolaryngology-Head and Neck Surgery | 1984

Production of Mucous Glycoproteins by Nasal Turbinates in Vitro

Carl A. Patow; James Shelhamer; Zvi Marom; Carolea Logun; Bruce Feldman; Jeffery N. Hausfeld; Michael Kaliner

An in vitro system of human nasal turbinate tissue culture has been developed. Nasal turbinate tissue resected during surgery for nasal obstruction is dissected free of bone, placed on absorbable gelatin sponges, and cultured with CMRL-1066 medium containing antibiotics. Viability of explants may be demonstrated both physiologically and histologically through a period of 4 weeks. 3H-glucosamine added to the medium is biosynthetically incorporated into mucous glycoprotein (MGP). Gel filtration column chromatography on Sephacryl S-1000 in 6M urea in 0.005M phosphate buffer demonstrates human turbinate MGP to fractionate with 85% of the radiolabel filtered and 15% excluded by the column. The excluded MGP fractionates with globular proteins of >20 × 106 daltons, while the fractions that enter the column filter with molecular sizes of 0.4 × 106 to 20 × 106 daltons. MGP synthesized by human lung airways has comparable sizing characteristics, suggesting a similarity in upper and lower airway mucus chemistry.


Otolaryngology-Head and Neck Surgery | 1995

CQI: Meeting the Mandate for Quality

Carl A. Patow

Educational objectives: To understand the principles of continuous quality improvement and to use these principles to enhance patient satisfaction through increased efficiency and improved quality of care.


Otolaryngology-Head and Neck Surgery | 1995

CQI: Beyond the Basics

Carl A. Patow; Michael S. Benninger

Educational objectives: To understand and use advanced techniques in teamwork, leadership, and analytical methods to improve quality and to recognize and apply advanced data display techniques such as Gant charts and flow charts in analyzing clinical processes.


The Journal of Allergy and Clinical Immunology | 1983

6 Nasal blood flow responses to nasal provocation

Howard M. Druce; Carl A. Patow; Robert F. Bonner; Peter Choo; Richard J. Summers; Michael Kaliner

Collaboration


Dive into the Carl A. Patow's collaboration.

Top Co-Authors

Avatar

Michael Kaliner

George Washington University

View shared research outputs
Top Co-Authors

Avatar

Carolea Logun

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Zvi Marom

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Abe M. Macher

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Bruce Feldman

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Dan L. Longo

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Henry Masur

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

James H. Shelhamer

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Ronald G. Steis

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Anthony S. Fauci

National Institutes of Health

View shared research outputs
Researchain Logo
Decentralizing Knowledge